1 JANUARY – 30 JUNI 2022
We strive to improve people's lives
NET SALES
EBITA
EARNINGS GROWTH
EBITA R12 MONTHS
P/WC
A quarter in change!
Just as expected, sales of COVID-19-related products have declined sharply compared to the corresponding quarter last year, when it was on record level. Growth is instead attributable to the acquisitions in Europe in recent years, as well as to the segments that reported weaker growth during the pandemic.
A leading player in Life Science
AddLife is a listed Swedish Medtech company active on the European market. AddLife owns and acquires companies in niche segments with offerings aimed primarily at the healthcare sector, from research to medical care. The subsidiaries are divided into two business areas. Labtech offers products, solutions and a wide range of diagnostic services, biomedical research and laboratory analysis. Medtech offers products, solutions and services in medical technology and home care.
Acquisitions during the interim period
During the interim period, four acquisitions have been completed and after the end of the interim period, another acquisition was completed. These acquisitions are estimated to contribute with annual net sales of approximately SEK 855m and approximately 350 employees.
